← Open Payments lookup

NICOLE STORLIE: Open Payments

NPI 1942573969 · VANCOUVER, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$778 in 22 payments from 11 companies in 2025. Trend: 2023 $687 · 2024 $538 · 2025 $778

Food & beverage: $778
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.7$181
E.R. Squibb & Sons, L.L.C.3$149
Supernus Pharmaceuticals, Inc.1$124
Axsome Therapeutics, Inc.1$81
Alkermes, Inc.2$60
ABBVIE INC.2$59
Otsuka America Pharmaceutical, Inc.2$38
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$26
Collegium Pharmaceutical, Inc.1$20
Janssen Pharmaceuticals, Inc1$20

Products named: INGREZZA, COBENFY, Qelbree, Auvelity, ARISTADA, VRAYLAR, REXULTI, CAPLYTA.

Industry payments across WA — which companies pay providers there.